Sample size re-estimation for covariate-adaptive randomized clinical trials

被引:5
作者
Li, Xin [1 ]
Ma, Wei [2 ]
Hu, Feifang [1 ]
机构
[1] George Washington Univ, Dept Stat, 801 22nd St NW, Washington, DC 20052 USA
[2] Renmin Univ China, Inst Stat & Big Data, Beijing, Peoples R China
基金
美国国家科学基金会; 中国国家自然科学基金;
关键词
early termination; efficiency; inference; interim analysis; type I error rate; BIASED COIN DESIGNS; STRATIFIED RANDOMIZATION; ALLOCATION; PERFORMANCE; MINIMIZATION; TESTS;
D O I
10.1002/sim.8939
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Covariate-adaptive randomization (CAR) procedures have been developed in clinical trials to mitigate the imbalance of treatments among covariates. In recent years, an increasing number of trials have started to use CAR for the advantages in statistical efficiency and enhancing credibility. At the same time, sample size re-estimation (SSR) has become a common technique in industry to reduce time and cost while maintaining a good probability of success. Despite the widespread popularity of combining CAR designs with SSR, few researchers have investigated this combination theoretically. More importantly, the existing statistical inference must be adjusted to protect the desired type I error rate when a model that omits some covariates is used. In this article, we give a framework for the application of SSR in CAR trials and study the underlying theoretical properties. We give the adjusted test statistic and derive the sample size calculation formula under the CAR setting. We can tackle the difficulties caused by the adaptive features in CAR and prove the asymptotic independence between stages. Numerical studies are conducted under multiple parameter settings and scenarios that are commonly encountered in practice. The results show that all advantages of CAR and SSR can be preserved and further improved in terms of power and sample size.
引用
收藏
页码:2839 / 2858
页数:20
相关论文
共 40 条
  • [1] Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - a randomized trial with quality of life as the primary outcome
    Anderson, H.
    Hopwood, P.
    Stephens, R. J.
    Thatcher, N.
    Cottier, B.
    Nicholson, M.
    Milroy, R.
    Maughan, T. S.
    Falk, S. J.
    Bond, M. G.
    Burt, P. A.
    Connolly, C. K.
    McIllmurray, M. B.
    Carmichael, J.
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 447 - 453
  • [2] OPTIMUM BIASED COIN DESIGNS FOR SEQUENTIAL CLINICAL-TRIALS WITH PROGNOSTIC FACTORS
    ATKINSON, AC
    [J]. BIOMETRIKA, 1982, 69 (01) : 61 - 67
  • [3] EVALUATION OF EXPERIMENTS WITH ADAPTIVE INTERIM ANALYSES
    BAUER, P
    KOHNE, K
    [J]. BIOMETRICS, 1994, 50 (04) : 1029 - 1041
  • [4] Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls
    Bauer, Peter
    Bretz, Frank
    Dragalin, Vladimir
    Koenig, Franz
    Wassmer, Gernot
    [J]. STATISTICS IN MEDICINE, 2016, 35 (03) : 325 - 347
  • [5] TREATMENT ALLOCATION PROCEDURE FOR SEQUENTIAL CLINICAL-TRIALS
    BEGG, CB
    IGLEWICZ, B
    [J]. BIOMETRICS, 1980, 36 (01) : 81 - 90
  • [6] Modification of sample size in group sequential clinical trials
    Cui, L
    Hung, HMJ
    Wang, SJ
    [J]. BIOMETRICS, 1999, 55 (03) : 853 - 857
  • [7] DEMETS DL, 1980, BIOMETRIKA, V67, P651
  • [8] Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial
    Elkashef, Ahmed
    Kahn, Roberta
    Yu, Elmer
    Iturriaga, Erin
    Li, Shou-Hua
    Anderson, Ann
    Chiang, Nora
    Ait-Daoud, Nassima
    Weiss, David
    McSherry, Frances
    Serpi, Tracey
    Rawson, Richard
    Hrymoc, Mark
    Weis, Dennis
    McCann, Michael
    Pham, Tony
    Stock, Christopher
    Dickinson, Ruth
    Campbell, Jan
    Gorodetzky, Charles
    Haning, William
    Carlton, Barry
    Mawhinney, Joseph
    Li, Ming D.
    Johnson, Bankole A.
    [J]. ADDICTION, 2012, 107 (07) : 1297 - 1306
  • [9] ROLE OF PROGNOSTIC STRATIFICATION IN PREVENTING BIAS PERMITTED BY RANDOM ALLOCATION OF TREATMENT
    FEINSTEIN, AR
    LANDIS, JR
    [J]. JOURNAL OF CHRONIC DISEASES, 1976, 29 (04): : 277 - 284
  • [10] Fisher LD, 1998, STAT MED, V17, P1551, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1551::AID-SIM868>3.0.CO